It has become increasingly clear that immune cytokines perform growth and differentiation functions in the nervous system similar to those performed in the immune system. In previous studies we have shown that interleukin-l/3 (IL-ID) raises substance P (SP) and the mRNA coding for its preprotachykinin precursor in cultured sympathetic superior cervical ganglia (SCG) Hart et al., 1991a) . The action of IL-1 is blocked both by depolarizption of the ganglia and by glucocorticoid hormones (Hart et al., 1991 a) . In the present report, we have found that IL-1 does not act directly upon neurons to raise SP, but rather induces the production of a soluble intermediate molecule that raises both SP and the cholinergic-specific enzyme ChAT. Its induction by IL-1 is blocked by the synthetic glucocorticoid hormone dexamethasone; its action is compromised under depolarizing conditions. Because medium conditioned by IL-1 (IL-1CM) is functionally similar to leukemia inhibitory factor (LIF), we sought to determine whether this molecule might be an active constituent of IL-1CM. lmmunoprecipltation with an antiserum directed against LIF eliminated large proportions of SP-inducing activity from IL-1 CM. In addition, steady-state levels of mRNA coding for LIF are increased by IL-1 treatment of SCG. These data suggest that LIF, induced by IL-l, may ultimately be responsible for the IL-1 induction of SP. [Key words: substance P, interleukin-7, leukemia inhibitory factor, sympathetic ganglia]
A central issue of neuroscience concerns the mechanisms underlying the ability of the nervous system to respond to environmental stimuli that are both normal and traumatic. The nervous system maintains an extensive repertoire of adaptive responses to its environment; one that has been widely studied is the change in the biosynthesis of new neurotransmitter molecules. The neonatal superior cervical ganglion (SCG) of the rat has been heavily scrutinized for its ability to alter its neurotransmitter complement in response to changing environmental signals (Johnson et al., 1976; Patterson and Chun, 1977; Kessler and Black, 1982; Kessler, 1984; see Jonakait and Black, 1989, for review). In one instance of dramatic neurotransmitter plasticity, substance P (SP) and the mRNA coding for its prohormonc precursor are increased in response to ganglion deaffcrentation (Kessler et al., 198 1; Roach et al., 1987) . The functional significance of this increase and the mechanisms underlying it have been unclear. However, since the increase in SP occurs in the face of damage to the ganglion, we sought to determine whether immune cy-tokines, released during such an injury, played a role in regulating the increase in SP.
In recent studies designed to test the role of immune cytokines in SCG responsiveness, we and others have found that interleukin-l/3 (IL-18) elicits a dramatic increase in SP-like immunoreactivity and in the mRNA coding for its preprotachykinin prohormone precursor in cultured neonatal SCG Freidin and Kessler, 199 1; Hart et al., 199 la) . The ability of the ganglion to respond to IL-l depends upon the absence of preganglionic electrical activity since mimicking presynaptic input prevents the IL-linduced ganglionic increase ofSP (Hart et al., I99 1 a) . Moreover, glucocorticoid hormones, known to truncate the immune response in a variety of settings, blunt the ganglionic response to IL-l as well (Hart et al., 199 la) .
While IL-1 induces SP in both explanted and dissociated SCG Freidin and Kessler, 1991) , it fails to induct SP in neuronal cultures that lack non-neuronal cells (Frcidin and Kessler, 1991) . The requirement for nonneuronal cells implies either that non-neuronal cells "enable" neuronal responsiveness, or alternatively, that non-neuronal cells, stimulated by IL-l, produce an intermediate molecule(s) that then stimulates neurons to produce SP.
While never localized within the SCG, leukemia inhibitory factor [LIF, also known as cholinergic differentiation factor; Johnson et al., 1976; Patterson and Chun, 1977; Fukada, 1985; Yamamori et al., 19901 promotes SP expression in SCG cultures (Nawa and Sah, 1990; Kessler and Freidin, 199 1; Rao et al., 1992) . Therefore, LIF suggested itself as a candidate for a possible molecular intermediate. In this study, we have confirmed that IL-l does not act directly on neurons to increase SP, and have found further that LIF is at least one of the molecular intermediates that promotes SP expression.
Materials and Methods

Cultures
of superior cervical ganglia.
Superior cervical (sympathetic) ganglia (SCG) from l-d-old rat pups were cultured either as explants or as dissociated cells. Explanted SCG were plated in 35 mm culture dishes coated with rat tail collagen. The medium contained Ham's Fl2 medium with 10% heat-inactivated fetal calf serum (FlZ/FCSIO) supplemented with SO-100 r&ml 7s NGF, 100 U/ml penicillin, and 100 &ml streptomycin. Cultures were grown at 37°C in an atmosphere of 5% CO,, and 100% humidity. When included, IL-ID (1 @ml) was added at explantation. For dissociated cultures, SCG were stripped of their connective tissue capsules and cleaned of residual blood. They were incubated in 0.25% trypsin in phosphate-buffered saline (PBS) for 45 min at 37°C and then dissociated bv aentle trituration. The cells were counted and plated at a density of < S&/dish (approximately I .25 x IO' cells/dishj in FI 21 FCSIO medium supplemented with 50 rig/ml 2.5s NGF, 100 U/ml penicillin, and 100 &ml streptomycin. Cells were fed every 2-3 d and remained in culture 8-10 d. When included, human recombinant ILl/3 (hrIL-lj3; I rig/ml) was added 48 hr after plating.
In order to produce "pure" neuronal cultures, dissociated SCG cultures were prepared as described above. Dividing non-neuronal cells were killed by the addition of IO PM cytosine B-D-arabinofuranoside after I and 2 d in culture. Examination of the cultures using a phasecontrast microscope revealed them to be virtually free of non-neuronal cells.
Preparation of IL-l-conditioned medium (IL-ICM). Ten to fifteen SCG were explanted in 35 mm dishes containing 1.5 ml of FIZ/FCSIO as described above. In some cases, ganglia were explanted in reduced serum medium (Opti-MEM, GIBCO) containing an N2 supplement (GIBCO, N2 medium). Medium was harvested after 4-5 d and stored at 4°C until further use. Two SCG per dish were harvested for SP radioimmunoassay (RIA) (see below). When IL-I-conditioned medium (IL-ICM) was tested on explant cultures, SCG were grown singly (one per well) in uncoated 96-well tissue culture plates or live per well in 24-well collagen-coated dishes. In each case, SCG were grown in a ratio of 100 @I of IL-I CM per SCG. IL-I CM was filter sterilized (0.22 pm Millex filter, Millipore Corp.) before use on naive cultures.
Immuno~recipita&&.
IL-ICM was incubated for 1 hr at 37°C with oolvclonal antibodies raised aaainst LIF. The antibody against LIF (I : &)'was raised against a IO amino acid synthetic peptidefound at the amino terminal end of LIF (Yamamori et al., 1990) . Preimmune serum served as a control. Protein A-conjugated sepharose beads (Sepharose 4B Fast, Sigma) were added to the medium and incubated for I hr with mixing. The slurry was microcentrifuged for 5 set and the supematant removed and filter sterilized. SP RIA. SP RIA was performed as described previously ) using a rabbit polyclonal antibody specific for SP. The linear range of the assay (between 2 and 50 pg) necessitated the use of diluted samples when performing the RIA.
Choline acetyltransjbase (ChAT) assay. ChAT was determined using the method of Fonnum (Fonnum, 1975) as modified by Martinez et al. (1985) .
Reverse transcription-polymerasechain reaction (RT-YCR).
Total cellular RNA was prepared-by the guanidinium-acid phenol method (Chomczvnski and Sacchi. 1987). modified as described (Hart et al., 199 I b) . &e microgram of RNA was reverse transcribed to cDNA in a 30 @I reaction [containing 50 mM Tris-HCI (pH 8.3). 75 mM KCI, 3 mM MgCI,, 0.1 mg/ml BSA, 40 U RNasin (Promega), 3 mM random hexamer primers (Promega), 0.5 mM each deoxynucleotidc triphosphate and 10 U/PI M-MLV reverse transcriptase (GIBCO/Bethesda Research Laboratories)] for 1 hr at 42°C. A 5 ~1 aliquot was amplified by PCR in a 50 ~1 reaction containing 0.2 mM concentrations of each deoxynucleotide triphosphate, 50 mM Tris-HCI (pH 9.0). I.5 mM MgCI,, 20 mM (NH,),S& ~C(M concentrations of each oligonucleotide primer, IO &i of c@P-dATP, and I U of Pyrostase polymerase (Molecular Genetic Resources, Tampa, FL). The PCR reaction was processed in a PerkinElmer-Cetus thermocycler programmed to the following conditions: 94°C 30 set, 60°C 30 set, and 72°C I min. Aliquots were removed at three successive cycles (the number of cycles to be used for quantitation was empirically determined by plotting a wider range of cycle aliquots and locating the range of detectable, constantly logarithmic amplification). The aliquots were electrophoresed on a 6Oh nondenaturing acrylamide gel that was then dried and autoradiographed. Individual gel bands were located by aligning with film, excised, and quantified by Cerenkov counting.
The LIF primers (LIF-I : S'CCCCTACTGCTCATTCTGCACTGG; LIF-2: S'TGCTAAGGAGCCCCCTCATGACGT)
were characterized by sequencing a sample cDNA product to determine its identity with published rat LIF sequence (Yamamori et al., 1990; C.-L. Liu, unpublished observations) . For each RNA sample tested, parallel PCR reactions were run with a "control" set of primers, such as rat cytoplasmic actin (Nude1 ct al., 1983) . The relative level of specific mRNA was expressed as a ratio ofcpm specific LIF PCR product to cpm cytoplasmic actin PCR product. This method has been used with other primers in our laboratory (Hart et al., 1993) .
In test experiments with other PCR primers (not shown), the quantitative reverse transcription-PCR (RT-PCR) reaction in our laboratory has successfully detected differences as small as 10% in a statistically significant fashion (measured by analysis of variance; 95% confidence limits were established using the Fisher test).
Materials.
Murine NGF, both 7s and 2.5S, were gifts from Michael Coughlin, McMaster University. SP antibody was a gift from Susan Lccman, Boston University School of Medicine. Antiserum to cholinergic differentiation factor (LIF) was a gift from Paul Patterson, California Institute of Technology. Recombinant IL-I receptor antagonist was a gift from Synergen (Boulder, CO). Human recombinant IL-lb was a gift from Lederle Labs (Pearl River, NY). Murine recombinant LIF (mrLIF) was purchased from Amrad (Kew, Victoria, Australia).
Results
The action I$ IL-I is mediated by an intermediate molecule
In order to test whether IL-l stimulated the production of a molecular intcrmediatc, medium conditioned by IL-1 (IL-1 CM) was tested for its effects on SP expression. Conditioned medium (CM) was obtained by culturing 10-l 5 ganglia for 4-5 d in the prcscncc or absence of IL-l/3 (see Materials and Methods). Ganglia harvested at the end of this initial culture period revealed the efficacy of IL-l in raising SP (Fig.  1) . Control CM and IL-1CM were then added to a naive set of SCG. To ensure that the increase in SP in the IL-lCM-treated cultures was not due to residual IL-1, a specific IL-l receptor antagonist (IL-1 ra; 200 @ml; Hannum et al., 1990 ) was added to the CM. In other experiments, this antagonist inhibited the IL-l-induced increase in SP by 50% (Hart et al., 1993) . CM from IL-l-treated cultures significantly raised SP in naive SCG (Fig. 1) . IL-lra did not inhibit the IL-lCM-induced increase, suggesting that the increase in SP was not due to residual IL-l, but rather was due to an intermediate molecule induced by IL-l. A dose-rcsponsc analysis of IL-1CM showed that a half-maximal response occurred at about a IO-fold dilution, while concentrations greater than 25% produced maximal SP production (Fig. 2) . A 32-fold dilution was ncccssary before IL-1CM achieved SP levels equivalent to those obtained with control (uninduccd) CM. Interestingly, levels of SP present in ganglia treated with control CM were significantly lowered by the IL-lra (Fig. 1 ). This suggests that cultured ganglia produce low levels of IL-1 --OSsibly neuronal in origin (Schultzberg et al., 1987; Freidin et al., 1992 IL-I CM elevates SP in both mixed dissociate and pure neuronal cultures Consistent with the reports ofothers (Freidin and Kessler, 199 I) , we found that IL-l raised SP above control levels in cultures comprising both neurons and non-neuronal cells (mixed dissociates; Fig. 3 ). In mixed dissociates, IL-1CM was strikingly more potent than IL-l itself in raising SP.
Pure neuronal cultures exposed to IL-l showed no increase in SP levels (see also Frcidin and Kessler, 199 1). However, IL-1CM produced a dramatic increase in SP (Fig. 3) . In pure neuronal cultures, IL-1CM raised SP significantly at dilutions as high as 1: 10 (data not shown). The induction of SP by IL-1 CM but not by IL-I confirms that the active molecule in IL-1CM is diffcrcnt from IL-1 itself.
We can conclude, then, that while IL-I itself does not act upon neurons to raise SP, it induces the production of a soluble molecular intermediate that is capable of inducing neuronal SP.
Characterization of the intermediate molecule(s)
In order to determine whether the intermediate was protein in nature, we tested the effects of boiling on its activity. Ganglia were grown in N2-supplemented medium (see Materials and Methods) with or without IL-1. Control CM and IL-1 CM were boiled for 30 mitt, filter sterilized, and resupplemented with N2 (GIBCO) and 7s NGF before being added to naive ganglia. Boiling severely reduced the ability of IL-1CM to raise SP in SCG explants (data not shown), suggesting that the active factor in IL-1 CM was proteinaceous. Fresh IL-1 added after boiling elevated SP in a naive set of explants, thereby establishing that boiling the medium had not compromised the survival or responsiveness of the explants (data not shown). In order to obtain an estimate of the size of the active IL-1CM molecule(s), ganglia were again cultured in N2 medium fold dilution with and without IL-1. IL-1 CM was fractionated using Centricon filters (Amicon Corp., Beverly, MA). The IL-1CM was passed through a Centricon-filter with 10 sample volumes. The dialysate was then passed through a Centricon-filter and centrifuged until the original volume was achieved. Unfractionated IL-1 CM as well as the three fractions resulting from this procedure were tested for SP-inducing activity. All samples were diluted 1 O-fold. SP-inducing activity was equally distributed between the 1 O-30 kDa and the > 30 kDa fractions (Fig. 4) . No activity appeared in the < 10 kDa fraction. IL-lra treatment of these fractions significantly depleted the 1 O-30 kDa fraction but had little effect on the >30 kDa fraction, which retained most of its activity (data not shown). These data suggested that activity in the lo-30 kDa fraction could be ascribed to residual IL-l (M, = 17,500) while the active SP-inducing intermediate had a molecular weight greater than 30 kDa. . IL-1CM prepared in the presence of veratrine raised SP well above control CM and even higher than with IL-1CM alone (Fig. 5A ). These data suggest that, far from inhibiting the production of IL-ICM, depolarizing agents actually enhance the IL-l-induced production of the SP-inducing intcrmediatc. Positive effects of depolarization on the elaboration ofgrowth-and survival-promoting factors have been noted by others (Brenneman et al., 1984; Cohen-Gory et al., 199 I) .
Explants treated with IL-1CM in the presence of 20 PM veratrine failed to show elevated SP (data not shown). However, since veratrine may be neurotoxic at high concentrations (Sun et al., 1992) , WC cultured SCG explants with IL-1 CM using 40 mM KC1 as an alternative cffector of depolarization. The action of IL-1CM in the presence of KC1 was dose dependent: IL-1 CM used at full strength was not affected by 40 mM KCl, while IL-ICM diluted lo-fold was substantially inhibited (Fig. 5B) .
These data taken together suggest that depolari;ration inhibits the IL-1 induction of SP not by inhibiting the production of the molecular intermediate(s), but rather by inhibiting the action of that intermediate on the neuron.
Dexamethasone blocks the production, not the action, of IL-ICM In previous experiments, we had shown that the synthetic glucocorticoid hormone dexamcthasonc (DEX) completely inhibits the IL-l induction of SP (Hart et al., 1991a) . In order to determine whether DEX blocked the action of IL-1CM on SP induction, pure neuronal cultures were rreated with IL-1 CM and 0.01 PM DEX. By itself, DEX had no effect on SP induction while IL-1 CM produced its expected effect (Fig. 6A) . However, DEX failed to block the action of IL-1 CM, suggesting that glucocorticoids do not block the action of the intermediate. However, DEX (0.0 1 PM) completely blocked the production of IL-1CM in IL-l-treated explants: IL-ICM, produced in the presence of DEX, was unable to alter SP expression in pure neuronal cultures, while IL-1 CM prepared from sister cultures in the absence of DEX raised SP well above control (Fig. 6R) . The DEX concentration was reduced to approximately 0.2 nM after dialysis and dilution. In addition, however, DEX had no effect on SP induction in neurons (see Fig. 6A ). These data suggest that the action of DEX in the inhibition of the IL-l induction of SP is to block of the production of the intermediate molecule(s).
The Journal of Nauroscknce, June 1993, 13 (6) IL-1 CA4 increases ChA T activity Since LIF is known to induce SP in cultured SCG (Nawa and Patterson, 1990; Nawa and Sah, 1990; Kessler and Freidin, 1991) it presented itself as a possible candidate for the active factor in IL-1CM. Since LIF also induces cholinergic characteristics in cultured sympathetic ganglion cells (Yamamori et al., 1990) then if LIF were the active factor in the IL-1 CM, IL-1 CM should induce the cholinergic phenotype as well. We therefore measured ChAT activity as one index of cholinergic expression. In explant cultures, IL-1, mrLIF (murine recombinant LIF), and IL-1 CM all increased ChAT activity significantly above control (Fig. 74 , suggesting a common spectrum of action.
As reported by others (Nawa and Patterson, 1990; Kessler and Freidin, 199 I) , LIF also raises ChAT activity in pure neuronal cultures. We therefore compared the abilities of IL-I and IL-1CM to raise ChAT in pure neuronal cultures (Fig. 78) . Similar to its mode of action on SP, IL-1 failed to raise ChAT in the absence ofnon-neuronal cells. IL-ICM, on the other hand,
Figure 7. Effects of IL-I, IL-ICM, and LIF on ChAT activity in explants (A) and pure neuronal dissociates (R). Explant cultures were treated with medium only, IO @ml hrIL-I, 50% IL-1 CM, or 1000 U/ ml LIF. Neuronal dissociate SCG cultures wcrc treated similarly except that 20% IL-1 CM was used. Data arc expressed as percentage ofcontrol ChAT activity (line). Each bar represents the mean k SEM of four dishes. *, p < 0.0003 compared with control.
dramatically elevated ChAT activity in pure neuronal cultures, confirming a second action common to both IL-1 CM and LIF.
Glucocorticoid hormones do not affect LIF activity DEX does not affect the ability of IL-1CM to raise SP (see above). Therefore, if LIF is the active molecule in IL-1 CM, then DEX should not affect the SP-inducing activity of LIF. DEX failed to alter the levels of SP induced by LIF in pure neuronal dissociates (data not shown), suggesting another similarity between IL-1CM and LIF.
Immunoprecipitation of LIF from IL-1 CM reduces SP-inducing activity In order to determine whether LIF is a constituent of IL-ICM, IL-1 CM was immunoprecipitated either with LIF antiserum or with preimmune serum (see Materials and Methods) . This antiserum immunoprecipitates cholinergic differentiating activity from heart cell-conditioned medium (Yamamori et al., 1990) and immunoprecipitates the SP-inducing activity of authentic (Fig. 8A) . Immunoprecipitation of the IL-1CM with LIF antiserum, but not with preimmune serum, dramatically and significantly reduced the ability of IL-1CM to induce SP in pure neuronal cultures (Fig. 8B) , suggesting that LIF might be one of the active molecules in IL-I CM.
LIF in SCG cultures
LIF mRNA is induced in IL-l-treated cultures
In order to determine whether LIF was produced in IL-l-treated cultures, RNA obtained from control and IL-l-treated explants was subjected to RT-PCR analysis using primers specific for rat LIF (see Materials and Methods). Freshly dissected ganglia had undetectable levels of LIF mRNA. After even a brief time in culture, low levels of the mRNA were evident. Treatment of the cultures with IL-I dramatically increased the steady-state levels of LIF mRNA (Fig. 9) . These data show directly that IL-1 induces LIF mRNA, making it likely that LIF is available in cultured ganglia to effect changes in SP expression. 
Discussion
It is by now abundantly clear that immune system cytokines arc important mediators through which environmental signals are translated into ncurobiological processes in general and neurotransmitter biosynthesis in particular. Molecules once thought to have actions restricted to the immune system are not only elaborated by the nervous system (Frei et al., 1985; Giulian et al., 1986; Tedeschi et al., 1986; Giulian and Ingeman, 1988; Hetier et al., 1988) but directly affect the proliferation (Fontana et al., 1980; Giulian and Baker, 1985; Giulian and Lachman, 1985; Benvenistc and Merrill, 1986; Saneto et al., 1986) survival (Larsson et al., 1989; Changet al., 1990 ) neurite outgrowth (Kamegai et al., 1990) and neurotransmitter expression (Scarborough ct al., 1989; Yamamori et al., 1990; Hart et al., 199 la) of cells of the nervous system as well. We (and others) have shown previously that IL-l induces SP in cultured sympathetic ganglia Barbany et al., 199 1; Freidin and Kessler, 199 1; Hart et al., 199 la) . We have now shown that the IL-l induction of SP expression depends upon the IL-1 induction of soluble intermediates. These intermediates must derive from non-neuronal cells since IL-l is unable to induce SP in pure neuronal cultures. Since specific antibodies against LIF immunoprecipitate SP-inducing activity from IL-I CM, one of the IL-l-induced factors is immunologically similar to LIF. The identification of LIF as an active factor in IL-ICM is strengthened by its shared spectrum of action with IL-1CM: IL-1CM and LIF both raise SP levels and increase ChAT activity, both arc inhibited by depolarizing stimuli (Rao et al., 1992) and DEX fails to affect their SP-inducing ability. Fractionation of IL-ICM shows that its activity is independent of IL-l, and its size ranges from 1 O-30 kDa to over 30 kDa, further implicating LIF (45 kDa; Fukada, 1985) . Finally, the induction by IL-I of Tha Journal of Nauroaeianoa. June 1993, 13(6) 2607 mRNA coding for LIF makes it highly likely that LIF is available in cultured ganglia to erect changes in SP expression.
While the full range of signal transduction from the IL-1 receptor is unknown, IL-1 activation of the transcription factor NF-KB is one possible means of effecting IL-l action (Osbom et al., 1989; Nonaka and Huang, 1990; Aniswicz et al., 1991 ). An NF-KB response element sequence is prcscnt in the promoter region of murine LIF (Stahl et al., 1990) .
The IL-1 induction of LIF has been reported in bone marrow (Wetzler et al., 199 1) . Moreover, it is reminiscent of the action of IL-I in the induction of NGF following sciatic nerve lesion (Lindholm et al., 1987) . In that instance, the induction by a cytokine of a growth factor required for maintenance and survival of injured neurons pointed to an important interaction between immune and nervous systems in recovery from injury.' However, in the present instance, the induction by a cytokine of a sympathetic neuron differentiation factor that raises both SP and ChAT not only emphasizes the interaction bctwcen immune and nervous systems, but also raises questions concerning the role(s) of both ACh and SP in recovery from ganglionic injury.
The upregulation of ChAT might be viewed simply as a homeostatic response by the ganglion to restore cholinergic presynaptic input destroyed by deafferentation and subsequent explantation into culture. Moreover, the role of SP in modulating sympathetic nicotinic receptor sensitivity in normal ganglia is well documented (Akasu et al., 1983; Role, 1984) . However, its role in deafferented ganglia could extend beyond this function.
For example, in CNS, at least, astrocytes express SP receptors both in culture (Torrens et al., 1989) and in vivo after injury (Mantyh et al., 1989) . While the functional significance of upregulating SP receptors on astrocytes is not entirely clear, one role may be to augment the SP-induced release of prostaglandins (Marriott et al., 1991) or to augment 8-adrenergic activation of astrocytes (Rougon et al., 1983) . The role if any, that SP may play in affecting Schwann cell metabolism in peripheral ganglia is, at this point, obscure.
The role of SP in stimulating immune function, however, is well documented (Bar-Shavit et al., 1980; Fewtrell et al., 1982; Payan et al., 1983; Stanisz et al., 1986; Matsuda et al., 1989; Moore et al., 1989; Muscettola and Grasso, 1990; Rameshwar et al., 1992) . SP is present in fibers innervating the spleen, thymus, and lymph nodes (Felten et al., 1985; Fink and Wcihe, 1988; Popper ct al., 1988; Weihe et al., 1989; Kurkowski et al., 1990 ) and contacting mast cells in the intestine (Bienenstock ct al., 1987) . While SP-positive nerve fibers have generally been thought to arise from sensory systems, sympathetic innervation of lymphoid organs is also well described (Felten et al., 1987; Maddens et al., 1989; Reder et al., 1989) . If SP, elevated in sympathetic ganglia after deaffcrcntation, is transported to these immune organs, it is anatomically poised to exert effects on the immune system. Current data suggest that this new pool of SP is not transported (at least to iris and pineal) (Kessler and Black, 1982) but direct data are lacking.
